FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OKMBRKBXMBMRBFQESOY3VV4MMM.jpg "Britain outlaws Palestinian militant group Hamas -interior minister")
